Quick Takeaways
- Novo Holdings A/S filed SCHEDULE 13G for Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO).
- Disclosed ownership: 5.3%.
- Date of event: 25 Mar 2025.
Novo Holdings A/S - 25 Mar 2025 SCHEDULE 13G Report for Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO)
- Filing Manager
- Novo Holdings A/S
- Reporting Manager
- Novo Holdings A/S
- Symbol
- ZBIO
- Shares outstanding
- 41,791,830 shares
- Disclosed Ownership
- 2,214,967 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Apr 2025, 21:47:58 UTC
- Date of event
- 25 Mar 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Novo Holdings A/S disclosed 5.3% ownership in Zenas BioPharma, Inc. Common Stock, par value $0.0001 (ZBIO) on 25 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 01 Apr 2025, 21:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | 5.3% | 2,214,967 | 2,214,967 | 0 | /s/ Barbara Fiorini | General Counsel, Finance & Operation |